Pipex Pharmaceuticals (PP) Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Source: http://Blog.QualityStocks.net/?p=11008Posted on Wednesday, July 9th, 2008 | In Current Market News, OTCBB Markets, Small & Micro Cap, Stocks to Watch
Pipex Pharmaceuticals, Inc. (AMEX: PP) recently announced that Nicholas Stergis, co-founder and vice chairman of the board of directors, has joined the executive management team as chief executive officer, replacing Steve H. Kanzer who will continue to serve as the company’s chairman. In addition, the company announced the resignations of Daniel J. Dorman, a director, and Dr. Charles L. Bisgaier, Pipex’s president, effective immediately.
As an original co-founder of Pipex Therapeutics, Inc., the predecessor company, Mr. Stergis has been vice chairman of the company’s board of directors since March 2007. He has also served as Pipex’s chief operating officer from 2001 until October 2006. Prior to co-founding Pipex, Mr. Stergis was co-founder, chief operating officer and director of Developmental Therapeutics, Inc., a cardiovascular drug development company. Mr. Stergis earned his his Bachelor of Science degree in biology from the University at Albany, State University of New York, and his Master of Science degree in biology from New York University.
Pipex Pharmaceuticals, a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, focuses on market opportunities with pharmaceuticals treating multiple sclerosis, dry age-related macular degeneration and fibromyalgia. The company’s strategy is to exclusively in-license proprietary, clinical-stage drug candidates with the ultimate goal of completing clinical testing, manufacturing and regulatory requirements to seek marketing authorizations via the filing of new drug applications.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Ensuring Effective Support for Growing Customer Base - November 25th, 2009
- Clenergen Corp.’s (CRGE.OB) Management Leads Innovative Push into Renewable Energy - November 25th, 2009
- Spending Growth Rises as Inflation Seems Manageable to Fed Despite Job Market - November 25th, 2009
- Stock Guru Featured Company: Quasar Aerospace Industries, Inc. (QASP.PK) - November 25th, 2009
- Stock Guru Featured Company: DecisionPoint Systems, Inc. (DNPI.OB) - November 25th, 2009
Age Related Macular Degeneration, Albany State University, amex, Autoimmune Diseases, Bachelor Of Science, Bachelor Of Science Degree, Cardiovascular Drug, Central Nervous System, Chief Executive Officer, Current Market News, Developmental Therapeutics, Drug Candidates, Executive Management Team, Kanzer, new york university, OTCBB Markets, Pharmaceuticals Inc, Pipex Pharmaceuticals, Pipex Therapeutics, Predecessor Company, Small & Micro Cap, Stergis, Stocks to Watch, Therapeutics Inc
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |




